Beam Therapeutics (BEAM) Other financing activities (2019 - 2026)

Beam Therapeutics (BEAM) has 6 years of Other financing activities data on file, last reported at $813000.0 in Q1 2026.

• Other financing activities for Q1 2026 came in at $813000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 110.37% YoY), and the FY2023 annual result was $631000.0, up 235.64% from the prior year.
• Other financing activities rose to $813000.0 in Q1 2026 per BEAM's latest filing, from $384000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $813000.0 in Q1 2026 and troughed at $6000.0 in Q1 2022.
• A 3-year average of $204000.0 and a median of $82500.0 in 2022 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2022 and 2023: Other financing activities tumbled 99.92% in 2022, then jumped 1436.0% in 2023.
• A 3-year view of Other financing activities shows it stood at $54000.0 in 2022, then surged by 611.11% to $384000.0 in 2023, then soared by 111.72% to $813000.0 in 2026.
• Business Quant data shows BEAM's Other financing activities at $813000.0 in Q1 2026, $384000.0 in Q3 2023, and $185000.0 in Q2 2023.